Photocure Financials
| PHO Stock | NOK 48.40 1.25 2.52% |
Photocure |
Understanding current and past Photocure Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Photocure's financial statements are interrelated, with each one affecting the others. For example, an increase in Photocure's assets may result in an increase in income on the income statement.
Photocure Stock Summary
Photocure competes with Cloudberry Clean, River Tech, Austevoll Seafood, Proximar Seafood, and Norwegian Air. Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PHOTOCURE ASA operates under Drug Manufacturers - Major classification in Norway and is traded on Oslo Stock Exchange. It employs 71 people.| Foreign Associate | USA |
| Instrument | Norway Stock View All |
| Exchange | Oslo Stock Exchange |
| ISIN | NO0010000045 |
| Business Address | Hoffsveien 4, Oslo |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.photocure.no |
| Phone | (47) 22 06 22 18 |
| Currency | NOK - Kroner |
You should never invest in Photocure without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Photocure Stock, because this is throwing your money away. Analyzing the key information contained in Photocure's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Photocure Key Financial Ratios
There are many critical financial ratios that Photocure's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Photocure reports annually and quarterly.| Return On Equity | -0.16 | |||
| Return On Asset | -0.0309 | |||
| Target Price | 141.67 | |||
| Number Of Employees | 97 | |||
| Beta | 0.79 |
Photocure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Photocure's current stock value. Our valuation model uses many indicators to compare Photocure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Photocure competition to find correlations between indicators driving Photocure's intrinsic value. More Info.Photocure is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Photocure's earnings, one of the primary drivers of an investment's value.Photocure Systematic Risk
Photocure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Photocure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Photocure correlated with the market. If Beta is less than 0 Photocure generally moves in the opposite direction as compared to the market. If Photocure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Photocure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Photocure is generally in the same direction as the market. If Beta > 1 Photocure moves generally in the same direction as, but more than the movement of the benchmark.
Photocure November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Photocure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Photocure. We use our internally-developed statistical techniques to arrive at the intrinsic value of Photocure based on widely used predictive technical indicators. In general, we focus on analyzing Photocure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Photocure's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.74 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 13.9 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 3.91 |
Other Information on Investing in Photocure Stock
Photocure financial ratios help investors to determine whether Photocure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photocure with respect to the benefits of owning Photocure security.